CIK 0001386570 · Large accelerated filer
Niagen Bioscience, Inc.
Sign in to watch- Ticker
- NAGE
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262940963
- Phone
- 310-388-6706
- Business address
- 10900 WILSHIRE BLVD, SUITE 600, LOS ANGELES, CA, 90024
- Former names
- ChromaDex Corp., CODY RESOURCES, INC.
- 8-K Event Material agreement · Executive or director change
- 4 Insider Changes in Ownership
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 10-Q Report Quarterly Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- CT ORDER Other Confidential Order
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Agreement ended
- SC 13D/A Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- 3 Insider Initial Statement of Ownership
- D Other Notice of Sales of Unregistered Securities
- 4/A Insider Changes in Ownership
- 3/A Insider 3/A
- 4/A Insider Changes in Ownership
- 8-K Event Unregistered share sale · Executive or director change
Page 45 of 50 · 981 filings